The Rosamund Stone Zander Translational Neuroscience Center strives to improve the lives of all children with brain disorders by fostering timely and efficient translational research.
Our core values are to maintain scientific rigor, collaboration, transparency, objectivity, diversity, equity, inclusion, belonging and access.
Our Advocacy and Research Partners
For Patients
Research Services
Research Funding
Featured News & Events
Rosamund Stone Zander Translational Neuroscience Center Selects Three Pilot Research Grant Awardees
The Rosamund Stone Zander Translational Neuroscience Center (RSZ TNC) at Boston Children’s Hospital is delighted to announce the selection of this year’s RSZ TNC Pilot Research Grant awardees. The mission of the RSZ TNC is to improve the lives of children with brain disorders via timely and efficient translation of scientific research through collaboration with Boston Children’s Hospital’s exceptional investigators, and in partnership with the external research community. To fulfill the goal of “timely and efficient translation,” this grant aims to support translational research on neurodevelopmental disorders within the domains of Preclinical Research, Drug Discovery, Therapeutic Development, Translational Biomarkers, and Gene-based Clinical Research and Trials.
Siddharth Srivastava, MD et al. New Publication in Annals of Neurology
Siddharth Srivastava, MD et al. published a new article titled “Survey of the Landscape of society Practice Guidelines for Genetic Testing of Neurodevelopmental Disorders” in the Annals of Neurology.
Chopra-Amiel-Gordon Syndrome (CAGS) Community Webinar
Dr. Maya Chopra and her research team at Boston Children’s Hospital are hosting an informational webinar for those impacted by or hoping to learn more about Chopra- Amiel-Gordon Syndrome (CAGS), a rare neurodevelopmental condition caused by changes in the ANKRD17 gene.